H. Mittermayer

1.7k total citations
46 papers, 843 citations indexed

About

H. Mittermayer is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, H. Mittermayer has authored 46 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 14 papers in Epidemiology and 12 papers in Pharmacology. Recurrent topics in H. Mittermayer's work include Bacterial Identification and Susceptibility Testing (11 papers), Antibiotic Resistance in Bacteria (10 papers) and Antimicrobial Resistance in Staphylococcus (9 papers). H. Mittermayer is often cited by papers focused on Bacterial Identification and Susceptibility Testing (11 papers), Antibiotic Resistance in Bacteria (10 papers) and Antimicrobial Resistance in Staphylococcus (9 papers). H. Mittermayer collaborates with scholars based in Austria, Germany and United Kingdom. H. Mittermayer's co-authors include Sigrid Metz-Gercek, Karina Krziwanek, Peter M. Elias, Peter Fritsch, Gunnar Kahlmeter, L. Stratchounski, Giuseppe Cornaglia, Waleria Hryniewicz, Fernando Baquero and Vincent Jarlier and has published in prestigious journals such as The Lancet, PLoS ONE and Emerging infectious diseases.

In The Last Decade

H. Mittermayer

43 papers receiving 767 citations

Peers

H. Mittermayer
G. C. Schito Italy
Marian Matushek United States
Michael Dul United States
A Kureishi Canada
D. Spelman Australia
Gerald A. Denys United States
T.G. Winstanley United Kingdom
A. Péchinot France
Fevronia Kolonitsiou Greece
A Gouby France
G. C. Schito Italy
H. Mittermayer
Citations per year, relative to H. Mittermayer H. Mittermayer (= 1×) peers G. C. Schito

Countries citing papers authored by H. Mittermayer

Since Specialization
Citations

This map shows the geographic impact of H. Mittermayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Mittermayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Mittermayer more than expected).

Fields of papers citing papers by H. Mittermayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Mittermayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Mittermayer. The network helps show where H. Mittermayer may publish in the future.

Co-authorship network of co-authors of H. Mittermayer

This figure shows the co-authorship network connecting the top 25 collaborators of H. Mittermayer. A scholar is included among the top collaborators of H. Mittermayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Mittermayer. H. Mittermayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zazgórnik, J & H. Mittermayer. (2011). Citric acid inhibits growth of Helicobacter pylori in vitro: a new strategy for eradication. Wiener klinische Wochenschrift. 123(1-2). 38–40. 6 indexed citations
2.
Krziwanek, Karina, Sigrid Metz-Gercek, & H. Mittermayer. (2010). Trends in the occurrence of MRSA strains in Upper Austria from 2006 to 2009. Clinical Microbiology and Infection. 17(6). 920–923. 9 indexed citations
3.
Maieron, A, Sigrid Metz-Gercek, Franz Hackl, et al.. (2010). Antiviral treatment of chronic hepatitis C in clinical routine. Wiener klinische Wochenschrift. 122(7-8). 237–242. 2 indexed citations
4.
Springer, Burkhard, Peter Much, Werner Ruppitsch, et al.. (2009). Methicillin-resistant Staphylococcus aureus: a new zoonotic agent?. Wiener klinische Wochenschrift. 121(3-4). 86–90. 61 indexed citations
5.
Metz-Gercek, Sigrid, et al.. (2009). Ten years of antibiotic consumption in ambulatory care: Trends in prescribing practice and antibiotic resistance in Austria. BMC Infectious Diseases. 9(1). 61–61. 39 indexed citations
6.
Krziwanek, Karina, Sigrid Metz-Gercek, & H. Mittermayer. (2009). Methicillin-ResistantStaphylococcus aureusST398 from Human Patients, Upper Austria. Emerging infectious diseases. 15(5). 766–769. 70 indexed citations
7.
Metz-Gercek, Sigrid & H. Mittermayer. (2008). The European surveillance activities EARSS and ESAC in the context of ABS International. Wiener klinische Wochenschrift. 120(9-10). 264–267. 10 indexed citations
8.
Krziwanek, Karina, S. Stumvoll, Maren Stämmler, et al.. (2008). MRSA in Austria—an overview. Clinical Microbiology and Infection. 14(3). 250–259. 23 indexed citations
9.
Krziwanek, Karina, et al.. (2007). PVL-positive MRSA in Austria. European Journal of Clinical Microbiology & Infectious Diseases. 26(12). 931–935. 36 indexed citations
10.
Cornaglia, Giuseppe, Waleria Hryniewicz, Vincent Jarlier, et al.. (2004). European recommendations for antimicrobial resistance surveillance. Clinical Microbiology and Infection. 10(5). 498–498. 1 indexed citations
11.
Cornaglia, Giuseppe, Waleria Hryniewicz, Vincent Jarlier, et al.. (2004). European recommendations for antimicrobial resistance surveillance. Clinical Microbiology and Infection. 10(4). 349–383. 119 indexed citations
12.
Krause, Robert, et al.. (1999). In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.. PubMed. 111(14). 549–54. 5 indexed citations
13.
Renner, Friedrich, et al.. (1997). Vibrio cholerae non-O1 septicaemia in a patient with liver cirrhosis and Billroth-II-gastrectomy. Journal of Infection. 34(1). 83–84. 17 indexed citations
14.
Kresken, Michael, D. Häfner, B. Wiedemann, et al.. (1994). Prevalence of fluoroquinolone resistance in Europe. Infection. 22(S2). S90–S98. 56 indexed citations
15.
16.
Mittermayer, H., et al.. (1988). Antibacterial treatment of otitis and sinusitis with ciprofloxacin and penicillin V — A comparison. Infection. 16(S1). S51–S54. 4 indexed citations
17.
Machka, K., I. Braveny, H. Dabernat, et al.. (1988). Distribution and resistance patterns ofHaemophilus influenzae: A European cooperative study. European Journal of Clinical Microbiology & Infectious Diseases. 7(1). 14–24. 68 indexed citations
18.
Rotter, M., Walter Koller, Michael Kundi, G. Wewalka, & H. Mittermayer. (1977). [Testmethod for the evaluation of procedures for the hygienic disinfection of hands. Part 1: Discription of testmethod (author's transl)].. PubMed. 164(5-6). 498–506. 1 indexed citations
19.
Mittermayer, H., et al.. (1976). [Further experimental investigations on the therapy of gas gangrene with ozone and oxygen (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 88(4). 141–4. 1 indexed citations
20.
Mittermayer, H. & M. Rotter. (1975). [Comparative investigations on the efficacy of tap water, some detergents and ethanol on the transient flora of the hands (author's transl)].. PubMed. 160(2). 163–72. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. C. Schito Breakdown of academic impact, for papers by Marian Matushek Breakdown of academic impact, for papers by Michael Dul Breakdown of academic impact, for papers by A Kureishi Breakdown of academic impact, for papers by D. Spelman Breakdown of academic impact, for papers by Gerald A. Denys Breakdown of academic impact, for papers by T.G. Winstanley Breakdown of academic impact, for papers by A. Péchinot Breakdown of academic impact, for papers by Fevronia Kolonitsiou Breakdown of academic impact, for papers by A Gouby
Rankless by CCL
2026